Society of Regenerative Sciences (India)

(Formerly known as Stem Cell Society (India))

Event Registration Membership Form

Indian Publications

Indian Publications

  1. Sharma A, Gokulchandran N, Kulkarni P, Sane H, Sharma R, Jose A, Badhe P. Cell Transplantation as a novel therapeutic strategy for Autism Spectrum Disorder: A clinical Study. Am J Stem Cells. 2020;9(5):89-100
  2. Sharma A, Gokulchandran N, Sane H, Kulkarni P, Nivins S, Maheshwari M, Badhe P. Therapeutic Effects of Cellular Therapy in a Case of Adult Autism Spectrum of Disorder. International Biological and Biomedical Journal. 2018 Mar 15;4(2):98-103.
  3. Alok Sharma, Nandini Gokulchandran, Pooja Kulkarni, Sarita Kalburgi, Shruti Kamat, Riddhima Sharma, Samson Nivins, Hemangi Sane, Prerna Badhe. "Improvements in a case of autism spectrum disorder after cell therapy as noted on PET CT brain scan" SJSC. 2017; 1(2):1-7.
  4. Sharma A, Gokulchandran N , Sane H, Kulkarni P, Pai S. A Case of Autism Showing Clinical Improvements after Cellular Therapy along with PET CT Evidence. J Stem Cell Res Ther. 2017;2(4):00070.
  5. Alok Sharma, Hemangi Sane, Nandini Gokulchandran, Prerna Badhe, Pooja Kulkarni and Suhasini Pai. Stem Cell Therapy in Autism Spectrum Disorders.Recent Advances in Autism SMGroup. 2017
  6. Sharma A, Sane H, Gokulchandran N, Badhe P, Patil A, Kulkarni P, Paranjape A. PET-CT scan shows decreased severity of autism after autologous cellular therapy: a case report. Autism Open Access. 2016;6(2);1-6.
  7. Sharma A, Gokulchandran N, Sane H, Patil A, Shetty A, Biju H, Kulkarni P, Badhe P. Amelioration of autism by autologous bone marrow mononuclear cells and neurorehabilitation: A case report. American Journal of Medical Case Reports. 2015;3(10):304-9.
  8. Sharma A, Gokulchandran N, Sane H, Bhovad P, Biju H, Shetty A, Kali M, Badhe P. Cell therapy effects portrayed on positron emission tomography of the brain serve as a new dimension for autism. Journal of Pediatric Neurology. 2014 Sep;12(03):151-6.
  9. Sharma A, Gokulchandran N, Shetty A, Kulkarni P, Sane H, Badhe P. Neuropsychiatric Disorder Tackled by Innovative Cell Therapy-A Case Report in Autism. J Stem Cell Res Transplant. 2014;1(1): 4.
  10. Sharma A, Gokulchandran N, Sane H, Kulkarni P, Thomas N, Paranjape A, Badhe P. Intrathecal autologous bone marrow mononuclear cell transplantation in a case of adult autism. Autism. 2013 Sep;3(2):113.
  11. Sharma A, Gokulchandran N, Shetty A, Sane H, Kulkarni P, Badhe P. Autologous bone marrow mononuclear cells may be explored as a novel potential therapeutic option for autism. J Clin Case Rep. 2013 May;3(282):2.
  12. Sharma A, Badhe P, Gokulchandran N, Kulkarni P, Mishra P, Shetty A, Sane H. An improved case of autism as revealed by PET CT scan in patients transplanted with Autologous bone marrow derived mononuclear cells. J Stem Cell Res Ther. 2013 May;3(139):2.
  13. Sharma A, Gokulchandran N, Sane H, Nagrajan A, Paranjape A, Kulkarni P, Shetty A, Mishra P, Kali M, Biju H, Badhe P. Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study. Stem cells international. 2013;2013. Article ID 623875, 13 pages.
  14. Sharma A, Chopra G, Gokulchandran N, Lohia M, Kulkarni P. Autologous Bone Marrow-derived Mononuclear Transplantation in Rett Syndrome. Asian Journal of Paediatric Practice. 2011;15(1).
  15. Sharma A, Gokulchandran N, Sane H, Kulkarni P, Kannan K, Shaikh Z, Biju H, Paranjape A, D’sa M, Badhe P. Autologous bone marrow mononuclear cell administration in a large cohort of 1011 autism spectrum disorder patients. Clinical Transplantation and Research. (In-print)
  16. Alok Sharma, Nandini Gokulchandran, Pooja Kulkarni, Sandhya Kiran Mullangi, Khushboo Bhagawanani, Vishal Ganar, Hemangi Sane, Prerna Badhe. Multiple Cellular Therapies Along with Neurorehabilitation in Spastic Diplegic Cerebral Palsy: A Case Report. Innov Clin Neurosci. 2020;17(10–12)
  17. Sharma A, Kulkarni P, Sane H, Gokulchandran N, Bhagwanani K, Badhe P, Nivins S. Therapeutic potential of Cell transplantation in a case of adult triplegic cerebral palsy. Global Journal For Research Analysis.2019;8:3.
  18. Sharma A, Kulkarni P, Varghese R, Sane H, Inamdar S, Kaur J, Nivins S, Gokulchandran N, Badhe P. Clinical translation of the benefits of cell transplantation in a case of cerebral palsy. Int J Biol Med Res. 2018;9(1):6254-8.
  19. Sharma A, Sane H, Gokulchandran N, Kulkarni P, Jose A., Ganar V, Nivins S, Badhe P. Cell transplantation: A novel therapeutic modality for cerebral palsy with co-morbid intellectual disability. Journal of Neuropsychiatry. 2018; Vol.2(2):6.
  20. Sharma A, Sane H, Kulkarni P, Sawant D, Bhagwanani K, Gokulchandran N, Bhade P, Nivins S. 18 FDG PET CT scan maps the effect of intrathecal transplantation of autologous bone marrow mononuclear cells (BMMNCs) in cerebral palsy. Indian journal of Stem Cell Therapy; 2018; Vol 3(1): 71-78.
  21. Sharma A, Gokulchandran N, Badhe P, Lakhanpal V, Kulkarni P, Pai S.Multidisciplinary Approach of Cellular Therapy with Neurorehabilitation in a Case of Mixed Cerebral Palsy. World J. Biol. Med. Science. 2017;Volume 4 (3) 70-74
  22. Sharma A, Gokulchandran N, Pai MS, Kulkarni MP, Sane H, Bhagwanani K, Badhe P. Diplegic Dystonic Cerebral Palsy Treated With Cellular Therapy: A Case Report. Journal- International Journal of Case Studies. 2017;6(3);15-19
  23. Sharma A, Sane H, Kalburgi S, Kulkarni P, Bhagwanani K, et al. Autologous Bone Marrow Mononuclear Cell Transplantation with Neurorehabilitation for Cerebral Palsy. J Stem Trans Bio 2017; 2(1): 110
  24. Sharma A, Sane H, Pai S, Kulkarni P, Raichur M, Kalburgi S. Intrathecal Administration of Autologous Bone Marrow Mononuclear Cells in a Case of Cerebral Palsy Coexisting with Autistic Features. Phys Med Rehabil Int. 2017;4(1):1110.
  25. Sharma A, Geng A, Sane H, Kulkarni P. Clinical neurorestorative progresses in cerebral palsy. Journal of Neurorestoratology 2016:4; 1-7
  26. Sharma A, Sane A, Kulkarni A, D’sa M, Gokulchandran N, Badhe P. Improved Quality of Life in a Case of Cerebral Palsy after bone marrow mononuclear cell transplantation. Cell J. 2015; 17(2): 389-394.
  27. Sharma A, Sane H, Gokulchandran N, Kulkarni P, Gandhi S, Sundaram J, Paranjape A, Shetty A, Bhagawanani K, Biju H and Badhe P. A clinical study of autologous bone marrow mononuclear cells for cerebral palsy patients: a new frontier,” Stem Cells International, Volume 2015, Article ID 905874, 11 pages.
  28. Sharma A, Sane H, Gokulchandran N, Badhe P, Kulkarni P, Paranjape A. Stem Cell Therapy for Cerebral Palsy – A Novel Option. Cerebral Palsy. Challenges for the future. 2014: 217-242
  29. Sharma A, Sane H, Paranjape A, Gokulchandran N, Kulkarni P and Nagrajan A, Badhe P. Positron Emission Tomography – Computer Tomography scan used as a monitoring tool following cellular therapy in Cerebral Palsy and Mental Retardation – A Case Report. Case Reports in Neurological Medicine. Volume 2013, Article ID 141983, 6 pages.
  30. Sharma A, Kulkarni P, Sane H, Gokulchandran N, Badhe P, Lohia M, Mishra P. Positron Emission Tomography- Computed Tomography scan captures the effects of cellular therapy in a case of cerebral palsy. Journal of clinical case reports. J Clin Case Rep. 2012; 2:195.
  31. Sane H, Nivins S, Paranjape P, Gokulchandran N, Badhe S, Varghese R, Badhe P, Sharma A. Severity of muscle impairment and its progression assessed using Musculo-skeletal Magnetic Resonance Imaging (MRI MSK) and Diffusion Tension Imaging (DTI) in 78 boys with Duchenne Muscular Dystrophy: A retrospective study (Pol J Radiol 2024; 89: e88-e105, DOI:
  32. Sharma A, Sane H, Gokulchandran N, Paranjape A, Shaikh Z, KM A, et al. Cell Therapy for Muscular Dystrophy. Advances in Muscular Dystrophy Research - From Cellular and Molecular Basis to Therapies [Working Title] [Internet]. 2023 Jan 11;
  33. Gokulchandran N, Sharma A, Sane H, Paranjape A, Varghese R, Bhade P. Autologous Bone Marrow Derived Mononuclear Cell Therapy in Muscular Dystrophy: A Review. Indian journal of Stem Cell Therapy; 2018; Vol 3(1): 40-55
  34. Sharma A; Sane H; Varghese R; Paranjape A; Nivins S; Inamdar S; Gokulchandran N; Badhe P. Potential benefits of serial cell transplantation in a case of Duchenne Muscular Dystrophy. Open Journal of Clinical and Medical Case Report, 2018;4(4); 1382
  35. Sharma A, Gokulchandran N, Paranjape A, Sane H, Badhe P. Stem cells as a therapeutic modality in Muscular Dystrophy. Chapter 2. Muscular Dystrophy. Avid Sciences. India. 2017
  36. Sharma A, Paranjape A, Sane H, Gokulchandran N, Sawant D, Shirke S, Nair V, Inamdar S, Badhe P. Effect of Cellular Therapy in a case of Limb Girdle Muscular Dystrophy. International Journal Of Current Medical And Pharmaceutical Research, 2017; 3(09):pp.2377-2381
  37. Alok S, Amruta P, Ritu V, Hemangi S, Nandini G, et al. Functional Improvements and Musculoskeletal Magnetic Resonance Imaging with Spectroscopy Changes following Cell Therapy in a Case of Limb Girdle Muscular Dystrophy. Int J cell Sci & mol biol. 2017; 2(4) : 555595.
  38. Sharma A, Gokulchandran N, Sane H, Lakhanpal V, Kulkarni P, et al. Stabilization Of Disease Progression In A Case Of Duchenne Muscular Dystrophy With Cellular Transplantation. Stem Cell Adv Res Ther. 2017; 2017: J112. DOI: 10.29011/SCRT-112. 000012
  39. Sharma A , Badhe P, Sane H, Pai S, Kulkarni P, Bhagwanani K, Gokulchandran N. Halting of functional decline in a case of Duchenne Muscular Dystrophy after cellular therapy. International Journal of Recent Advances in Multidisciplinary Research (IJRAMR),2017;04(02), pp.2293-2297
  40. Sharma, A., Badhe, P., Sane, H., Gokulchandran, N., & Paranjape, A. Role of Stem Cell Therapy in Treatment of Muscular Dystrophy. Muscular dystrophy. SMGebooks. July 2016. Dover, USA.
  41. Sharma A, Sane H, Kaur J, Gokulchandran N, Paranjape A, Yadav J, Badhe P. Autologous bone marrow mononuclear cell transplantation improves function in a case of Becker’s muscular dystrophy. American Based Research Journal. 2016;5(2):1-2.
  42. Sharma A, Sane H, Gokulchandran N, Sharan, R., Paranjape, A., Kulkarni, P., Yadav J, Badhe, P. Effect of Cellular Therapy in Progression of Becker’s Muscular Dystrophy: A Case Study. European Journal of Translational Myology. 2016;26(1):5522.
  43. Sharma A, Sane H, Kulkarni P, Mehta D, Kaur J, Gokulchandran N, Bhagwanani K, Badhe P. Effect Of Autologous Bone Marrow Mononuclear Cell Transplantation Coupled With Rehabilitation In Limb Girdle Muscular Dystrophy – A Case Report. Int J Med Res Health Sci. 2016, 5(12):1-7
  44. Sharma A, Sane H, Gokulchandran N, Gandhi S, Bhovad P, Khopkar D, Paranjape A, Bhagwanani K, Badhe P. The role of cell therapy in modifying the course of limb girdle muscular dystrophy- A Longitudinal 5-year study. Degenerative Neurological and Neuromuscular Disease 2015:5 93–102
  45. Sharma A, Sane H, Paranjape A, Bhagwanani K, Gokulchandran N, Badhe P. Autologous bone marrow mononuclear cell transplantation in Duchenne muscular dystrophy – a case report. American journal of case reports. 2014;15: 128-134.
  46. Sharma A, Sane H, Badhe P, Gokulchandran N, Kulkarni P, Lohiya M, Biju H, V.C.Jacob. A Clinical Study Shows Safety and Efficacy of Autologous Bone Marrow Mononuclear Cell Therapy to Improve Quality Of Life in Muscular Dystrophy Patients. Cell Transplantation. 2013; 22(1), S127–S138.
  47. Sharma A., Sane, H., Paranjape, A., Badhe, P., Gokulchandran, N., & Jacob, V. Effect of Cellular Therapy seen on Musculoskeletal Magnetic Resonance Imaging in a Case of Becker’s Muscular Dystrophy. Journal of Case Reports. 2013; 3(2): 440-447.
  48. Sharma A, Paranjape A, Sane H, Bhagawanani K, Gokulchandran N, Badhe P. Cellular transplantation alters the disease progression in Becker’s muscular dystrophy. Case reports in transplantation. 2013;2013.: 909328.
  49. Sharma A, Kulkarni P, Chopra G, Gokulchandran N, Lohia M, Badhe P. Autologous Bone Marrow Derived Mononuclear Cell Transplantation In Duchenne Muscular Dystrophy-A Case Report. Indian journal of Clinical Practice. 2012; 23 (3): 169-72.
  50. Alok Sharma, Hemangi Sane, Nandini Gokulchandran, Pooja Kulkarni, Alitta Jose, Vivek Nair, Rohit Das, Vaibhav Lakhanpal, and Prerna Badhe, Intrathecal transplantation of autologous bone marrow mononuclear cells in patients with sub-acute and chronic spinal cord injury: An open-label study, International Journal of Health Sciences 2020, 14(2):1-9.
  51. Alok Sharma, Hemangi Sane, Nandini Gokulchandran, Prerna Badhe, Amruta Paranjape, Pooja Kulkarni and Vivek Nair (September 16th 2019). Neuroregenerative-Rehabilitative Therapy for Spinal Cord Injury, Spinal Cord Injury Therapy, Antonio Ibarra, Elisa García-Vences and Gabriel Guízar-Sahagún, IntechOpen, DOI: 10.5772/intechopen.88808.
  52. Alok S, Prerna B, Suhasini, Hemangi S, Samson N, Pooja K, Amruta P, Dhara M, Nandini G.Functional Recovery and Functional Magnetic Resonance Imaging changes Following Cellular Therapy in a Case of Chronic Complete Spinal Cord Injury. Curr Trends Clin Med Imaging. 2017; 1(4): 555566.
  53. Alok Sharma, Hemangi Sane, Suhasini Pai, Pooja Kulkarni, Amruta Paranjape, V C Jacob, Joji Joseph, Sanket Inamdar, Sarita Kalburgi, Nandini Gokulchandran, Prerna Badhe, Samson Nivins. Functional and symptomatic improvement after cellular therapy in a pediatric case of chronic traumatic incomplete SCI. J Stem Cell Regen Biol 2017; 3(1): 1- 7.
  54. Alok Sharma, Hemangi Sane, Dipti Khopkar, Nandini Gokulchandran,Varghese Chako Jacob, Joji Joseph, Prerna Badhe. Functional recovery in chronic stage of spinal cord injury by Neurorestorative Approach. Case Reports in Surgery 2014 Volume 2014, pages 1-4
  55. Alok Sharma, Hemangi Sane, Dipti Khopkar, Nandini Gokulchandran, Hema Biju, V C Jacob, Prerna Badhe. Cellular therapy targeting Functional outcome in a case of Cervical Spinal Cord Injury. Advances in Stem Cells 2014 (2014) Article ID 149752.
  56. Sharma A, Sane H, Gokulchandran N, Kulkarni P, Thomas N, et al. (2013) Role of Autologous Bone Marrow Mononuclear Cells in Chronic Cervical Spinal Cord Injury-A Longterm Follow Up Study. J Neurol Disord 1: 138.
  57. Sharma A, Gokulchandran N, Sane H, Badhe P, Kulkarni P, Lohia M, Nagrajan A, Thomas N. Detailed analysis of the clinical effects of cell therapy for thoracolumbar spinal cord injury: an original study. Journal of Neurorestoratology. 2013; 1:13-22.
  58. Alok Sharma, Prerna Badhe, Pooja Kulkarni, Nandini Gokulchandran, Guneet Chopra, Mamta Lohia, Hema Biju, V.C.Jacob. Autologous Bone Marrow Derived mononuclear cells for the treatment of Spinal Cord Injury. The Journal of Orthopaedics. 2011; 1(1): 33-36.
  59. Sharma A, Sane H, Paranjape A, Jose A, Mehta D, Inamdar S, Badhe P, Gokulchandran N. Cellular therapy improves brain metabolism in a case of chronic ischemic Stroke. International Journal of Science and Healthcare Research. 2019; vol 4 (1): 2455-7587.
  60. Alok Sharma, Hemangi Sane, Nandini Gokulchandran, Pooja Kulkarni, Rishabh Sharan, Amruta Paranjape, Prerna Badhe Effect of Cellular Therapy Monitored on Positron Emission Tomography - Computer Tomography Scan in Chronic Hemorrhagic Stroke: A Case Report. Archiv Neurol Neurosurgery, 2016 Volume 1(1): 22-25
  61. Alok Sharma, Hemangi Sane , Amruta Paranjape, Nandini Gokulchandran , Sushant Gandhi, Prerna Badhe. Benefits of Autologous Bone Marrow Mononuclear Cell Transplantation in Chronic Ischemic Pontine Infarct. Journal Of Case Reports 2016;6(1):80-85
  62. Alok Sharma, Hemangi Sane, Nandini Gokulchandran, Dipti Khopkar, Amruta Paranjape, Jyothi Sundaram, Sushant Gandhi, and Prerna Badhe. Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke Stroke Research and Treatment,2014; Volume 2014, pages 1-9.
  63. Alok Sharma, Hemangi Sane, Anjana Nagrajan, et al., “Autologous Bone Marrow Mononuclear Cells in Ischemic Cerebrovascular Accident Paves Way for Neurorestoration: A Case Report,” Case Reports in Medicine, vol. 2014, Article ID 530239, 5 pages, 2014. doi:10.1155/2014/530239.
  64. Dr. Alok Sharma, Dr. Hemangi Sane, Dr. Prerna Badhe, Ms. Pooja Kulkarni, Dr. Guneet Chopra, Dr. Mamta Lohia, Dr. Nandini Gokulchandran. Autologous Bone Marrow Stem Cell Therapy shows functional improvement in hemorrhagic stroke- a case study. Indian Journal of Clinical Practice, 2012:23(2):100-105.
  65. Sharma A., Sane H., Paranjape A., Pradhan R., Varghese R., Biju H., Nair V., Sawant D., Gokulchandran N., Badhe P. Role of reproductive hormonal status on the outcome of autologous bone marrow mononuclear cells intrathecal transplantation combined with standard treatments in patients with amyotrophic lateral sclerosis - a controlled cohort study, Global Journal of Research Analysis, 2021 July 10;7
  66. Sharma A., Sane H., Paranjape A., Varghese R., Nair V., Biju H., Sawant D., Gokulchandran N., Badhe P. Improved survival in Amyotrophic Lateral Sclerosis patients following Autologous Bone Marrow Mononuclear Cell Therapy: A Long term 10-year retrospective study, Journal of Neurorestoratology, 2021, 9(2): 117–136
  67. Sharma A, Sane H, Paranjape A, Pradhan R, Das R, Biju H, Gokulchandran N, Badhe P. Multiple doses of cell therapy and neurorehabilitation in amyotrophic lateral sclerosis: A case report. Clin Pract. 2020 Sep 28;10(3):1242. doi: 10.4081/cp.2020.1242. PMID: 33072247; PMCID: PMC7533601.
  68. Dr. Hemangi Sane, Ritu varghese, Dr. Amruta paranjape, Dr. Reena Jain, Dr. Nandini Gokulchandran, Dr. Prerna Bhade, Dr. Alok Sharma. Correlation of Testosterone levels with progression of Amyotrophic Lateral Sclerosis in Males: A Cross-Sectional Study. Advance Research Journal of Multidisciplinary Discoveries, 2019; 37(1).
  69. Alok Sharma, Hemangi Sane, Nandini Gokulchandran, Prerna Badhe, Amruta Paranjape, Radhika Pradhan, Rohit Das and Hema Biju (October 23rd 2019). Stem Cell Therapy in Motor Neuron Disease [Online First], IntechOpen, DOI: 10.5772/intechopen.87116.
  70. Sharma, A., Sane, H., Pradhan, R., Paranjape, A., Gokulchandran, N., Kaur, J., Das, R., & Badhe, P. Neuroregenerative Rehabilitation Therapy with long-term Lithium in a Male Amyotrophic Lateral Sclerosis Patient: A Case Report. International Journal of Medical Science and Clinical Invention, 2019, 6(2): 4337-4344.
  71. Alok Sharma, Hemangi Sane, Sarita Kaliburgi, Amruta Paranjape, Nandini Gokulchandran, Prerna Badhe,“Potential Benefits of Cellular Transplantation in a Patient with Amyotrophic Lateral Sclerosis”. Current Opinions in Neurological Science 1.2 (2017): 31-43
  72. Sharma A, Sane H, Sawant D, Paranjape A, Inamdar S, Kaur J, Gokulchandran N, Badhe P. Cellular Therapy in Amyotrophic Lateral Sclerosis: A Case Report; International Journal of Recent Advances in Multidisciplinary Research. 2017;1(4):2605-2609
  73. Hemangi Sane, Alok Sharma, Nandini Gokulchandran, Sarita Kalburgi, Amruta Paranjape, Prerna Badhe. Neurorestoration in Amyotrophic Lateral Sclerosis - A case report. Indian Journal of Stem Cell therapy. 2016; 2(1):29-37
  74. Alok K Sharma , Hemangi M Sane , Amruta A Paranjape , Nandini Gokulchandran, Anjana Nagrajan, Myola D’sa, Prerna B Badhe. The effect of autologous bone marrow mononuclear cell transplantation on the survival duration in Amyotrophic Lateral Sclerosis - a retrospective controlled study. Am J Stem Cells 2015;4(1).
  75. Alok Sharma, Prerna Badhe, Omshree Shetty, Pooja Vijaygopal, Nandini Gokulchandran, V.C. Jacob, Mamta Lohia, Hema Biju, Guneet Chopra. Autologous bone marrow derived stem cells for motor neuron disease with anterior horn cell involvement. Bombay hospital journal. 2011; 53(1): 71- 75.
  76. Sharma, A., Gokulchandran, N., Varghese, R., Sane, H., Ganar, V., Kulkarni, P., Nivins, S., & Badhe, P. (2019). Improved brain function in an adult case of Intellectual Disability with Autism Spectrum Disorder following Cell Therapy. International Journal of Medical Science and Clinical Invention, 6(2), 4294-4301.
  77. Alok Sharma, Hemangi Sane, Nandini Gokulchandran, Suhasini Pai, Pooja Kulkarni, Vaishali Ganwir, Maitree Maheshwari, Ridhima Sharma, Meenakshi Raichur, Samson Nivins, MS; Prerna Badhe. An open label proof of concept study of intrathecal Autologous Bone Marrow Mononuclear Cells transplantation in Intellectual Disability. Stem cell research and therapy. 2018;9(19):1-14.
  78. Sharma A, Gokulchandran N, Sane H, Pai S, Kulkarni P, et al. Cognitive Changes after Cellular Therapy in a Case of Intellectual Disability. J Transplant Stem Cell Biol. 2017;4(1): 4.
  79. Sharma A, Sane H, Pooja K, Akshya N, Nandini G, Akshata S. (2015) Cellular Therapy, a Novel Treatment Option for Intellectual Disability: A Case Report. J Clin Case Rep 5:483. doi: 10.4172/2165- 7920.1000483.
  80. Sharma, A. , Gokulchandran, N. , Sane, H. , Desai, S. , Kulkarni, P. , Badhe, P. Stem Cell Therapy for Learning Disability. In: Misciagna, S. , editor. Learning Disabilities - Neurobiology, Assessment, Clinical Features and Treatments [Internet]. London: IntechOpen; 2022 [cited 2022 Mar 31].
  81. Sharma AK, Sane HM, Kulkarni PP, Gokulchandran N, Biju H, Badhe PB. Autologous bone marrow mononuclear cell transplantation in patients with chronic traumatic brain injury- a clinical study. Cell Regen. 2020 Jun 2;9(1):3.
  82. Dr. Alok Sharma, Dr. Hemangi Sane, Dr. Vishal Chafle, Alitta Jose, Pooja Kulkarni, Samson Nivins, Dr. Dhara Mehta, Dr. Nandini Gokulchandran, Dr. Prerna Badhe.Improvements in a case of sensory ataxia through cell transplantation. International Journal of Medical and Biomedical Studies, 2019; 3(2).
  83. Sharma A, Gokulchandran N, Sane H, Nivins S, Kulkarni P, Mane V, Maheshwari M, Badhe P. Efficacy of Autologous Bone Marrow Derived Mononuclear Cells in the treatment of neurodeficits in Down’s Syndrome: A case report. British Journal of BioMedical Research. 2018, 2(2): 281-288.
  84. Dr. Alok Sharma, Ms. Pooja Kulkarni, Dr. Nandini Gokulchandran, Dr. Hemangi Sane, Dr. Prerna Badhe, Ms. Ridhima Sharma, Mr. Samson Nivins. Cognitive and functional improvements in a case of Global developmental disorder after cellular therapy Indian Journal of Applied Research.
  85. Alok Sharma, Nandini Gokulchandran,Hemangi Sane,Suhasini Pai , Pooja Kulkarni, Khushboo Bhagwanani, Nayana Shet, Mr. Samson Nivins, Prerna Badhe. Functional improvements monitored by Positron Emission Tomography imaging after cell transplantation in severe chronic Traumatic Brain Injury. International Journal of Surgery and Medicine. March 2018
  86. Dr. Alok Sharma, Hemangi Sane, Nandini Gokulchandran, Prerna Badhe, Mrs. Suhasini Pai, Pooja Kulkarni, Jayanti Yadav, Sanket Inamdar. Cellular Therapy for Chronic Traumatic Brachial Plexus Injury-A case report. Advanced Biomedical Research journal. 2018;7:51
  87. Alok Sharma, Hemangi Sane, Nandini Gokulchandran, Prerna Badhe, Pooja Kulkarni, Suhasini Pai, Ritu Varghese, Amruta Paranjape. Stem cell therapy in pediatric neurological disabilities In Physical disabilities. Intech 2017
  88. Alok Sharma, Hemangi Sane , Sarita Kalburgi , Pooja Kulkarni , Sanket Inamdar, Khushboo Bhagwanani ,Nandini Gokulchandran , Prerna Badhe. Autologous Bone Marrow Mononuclear Cell Transplantation for Multiple System Atrophy type C- A Case Report. American Based Research Journal. 2017; 6(1);40-45.
  89. Alok Sharma Hemangi Sane Pooja Kulkarni Nandini Gokulchandran Dhanashree Sawant Samson Nivins Prerna Badhe. Effect of Cell Transplantation in a Chronic Case of Traumatic Brain Injury. Transplantation Open. 2016 Volume 1(1): 22-25
  90. Alok Sharma, Ziad M Al Zoubi. Rethinking on ethics and regulations in cell therapy as part of neurorestoratology. Journal of Neurorestoratology 2016:4 1–14
  91. Alok Sharma, Hemangi Sane, Pooja Kulkarni, Nandini Gokulchandran, Prerna Badhe Cellular therapy in Neurodevelopmental disorders. Indian Journal of Stem Cell therapy. 2016; 2(1):64-73
  92. Alok Sharma, Nandini Gokulchandran, Hemangi Sane, Prerna Badhe, Amruta Paranjape. Current global trends in regulations for stem cell therapy and the way ahead for India. Indian Journal of Stem Cell therapy. 2016; 2(1):5-16
  93. Nandini Gokulchandran, Alok Sharma , Hemangi Sane , Prerna Badhe , Pooja Kulkarni. Stem Cell Therapy as a Treatment Modality for Neurotrauma. Indian Journal of Stem Cell therapy. 2015; 1(1):21-26.
  94. Dr. Alok K. Sharma, Dr. Hemangi Sane , Dr. Nandini Gokulchandran , Dr. Amruta Paranjape , Ms. Pooja Kulkarni , Dr. Prerna Badhe. The need to review the existing guidelines and proposed regulations for stem cell therapy in India based on published scientific facts, patient requirements, national priorities and global trends. Indian Journal of Stem Cell therapy. 2015; 1(1):7-20.
  95. Alok Sharma, Prerna Badhe, Nandini Gokulchandran, Pooja Kulkarni, Hemangi Sane, Mamta Lohia, Vineet Avhad. Autologous bone marrow derived mononuclear cell therapy for vascular dementia - Case report. Journal of stem cell research and therapy. 2:129.
  96. Alok Sharma, Hemangi Sane, Pooja Kulkarni, Jayanti Yadav, Nandini Gokulchandran, Hema Biju, Prerna Badhe. Cell therapy attempted as a novel approach for chronic traumatic brain injury - a pilot study. SpringerPlus,2015; 4:26.
  97. Sharma A, Sane H, Paranjape A, Gokulchandran N, Takle M, et al. Seizures as an Adverse Event of Cellular Therapy in Pediatric Neurological Disorders and its Prevention. J Neurol Disord; 2014;2:164.
  98. Alok Sharma, Hemangi Sane, Amruta Paranjape, Nandini Gokulchandran, Hema Biju, Myola D’sa, Prerna Badhe. Cellular Transplantation May Modulate Disease Progression In Spino-Cerebellar Ataxia – A Case Report. Indian Journal Of Medical Research And Pharmaceutical Sciences. August 2014; 1(3).
  99. Alok Sharma, Nandini Gokulchandran, Guneet Chopra, Pooja Kulkarni, Mamta Lohia, Prerna Badhe, V.C. Jacob. Administration of autologous bone marrow derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life. Cell Transplantation, 2012; 21 Supp 1: S1 – S12.
  100. A. Sharma, P. Badhe, N. Gokulchandran, P. Kulkarni, V.C Jacob, M. Lohia, J. George Joseph, H. Biju, G. Chopra. Administration of Autologous bone marrow stem cells intrathecally in Multiple Sclerosis patients is safe and improves their quality of life. Indian Journal of clinical Practice. 2011:21(11):622-625.
  101. Sharma A, Gokulchandran N, Kulkarni P, Chopra G. Application of autologous bone marrow stem cells in giant axonal neuropathy. Indian J Med Sci 2010;64:41-4..
  102. Alok sharma, Hemangi Sane, Nandini Gokulchandran, Amruta Paranjape, Pooja Kulkarni, Prerna Badhe. Recent development in ethical understanding and regulations for clinical application of stem cells.Indian journal of Stem Cell Therapy; 2018; Vol 3(1): 5-20.
  103. Alok Sharma, Rohit Kulkarni, Hemangi Sane, Nilkanth Awad, Abhijit Bopardikar, Anagha Joshi, Sujata Baweja, Mohan Joshi, Chandra Vishwanathan, Nandini Gokulchandran, Prerna Badhe, Mazhar Khan, Amruta Paranjape, Pooja Kulkarni, Arjun K Methal: Phase 1 clinical trial for intravenous administration of mesenchymal stem cells derived from umbilical cord and placenta in patients with moderate COVID-19 virus pneumonia: results of stage 1 of the study. Am J Stem Cells 2022;11(3):37-55.
  104. Bhartiya M, Kumar A, Singh RK, Radhakrishnan DM, Rajan R, Srivastava AK. Mesenchymal Stem Cell Therapy in the Treatment of Neurodegenerative Cerebellar Ataxias: a Systematic Review and Meta-analysis. Cerebellum. 2022 Apr 22. doi: 10.1007/s12311-022-01403-6. Epub ahead of print. PmiD: 35451803.
  105. Sinha, Rupam1; Sarkar, Soumyabrata1; Khaitan, Tanya1,; Dutta, Soumyajit1. Duchenne muscular dystrophy: Case report and review. Journal of Family Medicine and Primary Care: Jul–Sep 2017 - Volume 6 - Issue 3 - p 654-656 doi: 10.4103/2249-4863.222015.
  106. Purandare C, Shitole DG, Belle V, Joshi M. Stem Cell Therapy for Hemorrhagic Stroke: A Single Case Study Report. Research & Reviews: A Journal of Neuroscience. 2(2), August 2012, Pages 22-26
  107. Bhasin A, Kumaran SS, Bhatia R, Mohanty S, Srivastava MVP. Safety and Feasibility of Autologous Mesenchymal Stem Cell Transplantation in Chronic Stroke in Indian patients. A four-year follow up. J Stem Cells Regen Med. 2017 May 30;13(1):14-19. PubMed PmiD: 28684893; PubMed Central PMCID: PMC5494434.
  108. Bhasin A, Srivastava M, Bhatia R, Mohanty S, Kumaran S, Bose S. Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke. J Stem Cells Regen Med. 2012;8(3):181–189.
  109. Bhasin A, Srivastava MP, Mohanty S, Bhatia R, Kumaran SS, Bose S. Stem cell therapy: a clinical trial of stroke. Clinical Neurology and Neurosurgery. 2013 Jul 1;115(7):1003-8.
  110. Kumar A, Prasad M, Jali VP, Pandit AK, misra S, Kumar P, Chakravarty K, Kathuria P, Gulati A. Bone marrow mononuclear cell therapy in ischaemic stroke: a systematic review. Acta Neurologica Scandinavica. 2017 May;135(5):496-506.
  111. Bhasin A, Srivastava MP, Mohanty S, Vivekanandhan S, Sharma S, Kumaran S, Bhatia R. Paracrine mechanisms of intravenous bone marrow-derived mononuclear stem cells in chronic ischemic stroke. Cerebrovascular diseases extra. 2016;6(3):107-19.
  112. Kumar A, Rawat D, Prasad K. Stem Cell Therapy in Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ann Indian Acad Neurol. 2021
  113. Tiwari S, Khan S, Kumar SV, Rajak R, Sultana A, Pasha SA, Gauba D, Ghosh P, Khurana T, Kulkarni A, Reddy YP, Khan AA, Sharma VK. Efficacy and safety of neural stem cell therapy for spinal cord injury: A systematic literature review. Therapie. 2021 May-Jun;76(3):201-210. doi: 10.1016/j.therap.2020.06.011. Epub 2020 Jun 27. PmiD: 32709426.
  114. Saini R, Pahwa B, Agrawal D, Singh PK, Gujjar H, mishra S, Jagdevan A, misra MC. Efficacy and outcome of bone marrow derived stem cells transplanted via intramedullary route in acute complete spinal cord injury - A randomized placebo controlled trial. J Clin Neurosci. 2022 Jun;100:7-14. doi: 10.1016/j.jocn.2022.03.033. Epub 2022 Mar 31. PmiD: 35367733.
  115. Shroff, G., Gupta, A., & Barthakur, J. K. (2014). Therapeutic potential of human embryonic stem cell transplantation in patients with cerebral palsy. Journal of Translational Medicine, 12(1).
  116. Shroff, G., & Das, L. (2014). Human embryonic stem cell therapy in cerebral palsy children with cortical visual impairment: a case series of 40 patients. Journal of Cell Science & Therapy, 5(6), 1.
  117. Shroff G. Human embryonic stem cells (hESCs) in the treatment of emphysematous COPD: a case report. Clin Case Rep. 2015 Jul;3(7):632-4. doi: 10.1002/ccr3.310. Epub 2015 Jun 5. PMID: 26273458; PMCID: PMC4527812.
  118. Shroff, Geeta. (2015). Use of Human Embryonic Stem Cells in the Treatment of Parkinsons Disease: A Case Report. International Journal of Emergency Mental Health and Human Resilience. 17. 10.4172/1522-4821.1000260.
  119. Shroff, G. (2015). Human embryonic stem cell for the treatment of multiple sclerosis: A case report. Case Reports International, 4(2), 1–5.
  120. Shroff, Geeta. (2015). A novel approach of human embryonic stem cells therapy in treatment of Friedrich's Ataxia. International Journal of Case Reports and Images. 6. 261. 10.5348/ijcri-201503-CS-10054.
  121. Shroff, G. (2015). Human embryonic stem cells in the treatment of spinocerebellar ataxia: a case series. Journal of Clinical Case Reports, 05(01).
  122. Shroff, G., & Barthakur, J. (2015). Safety and efficacy of human embryonic stem cells for the treatment of cerebrovascular accident: a case series. Journal of Medical Research/˜the œJournal of Medical Research, 15(2). Retrieved from
  123. Shroff, Geeta. (2015). Evaluation of Wound Healing Ability with Human Embryonic Stem Cells in Patients with Non-Healing Wounds: A Case Series. Journal of Pigmentary Disorders. 02. 10.4172/2376-0427.1000191.
  124. Shroff G, Barthakur JK. Safety of human embryonic stem cells in patients with terminal/incurable conditions- a retrospective analysis. Ann Neurosci. 2015 Jul;22(3):132-8. doi: 10.5214/ans.0972.7531.220303. PMID: 26130921; PMCID: PMC4481559.
  125. Shroff, G., Agarwal, P., Mishra, A., & Sonowal, N. (2015). Human Embryonic Stem Cells in Treatment of Spinal Cord Injury: A Prospective Study. Journal Of Neurology Research, 5(3), 213-220.
  126. Shroff, G. (2015). Treatment of Lyme disease with human Embryonic stem cells: a case series. Journal of Neuroinfectious Diseases, 06(01).
  127. Shroff, G. (2015). Clinical effect of human embryonic stem cells therapy in two cases of cerebral palsy. Journal of Neurology Research, 5(3), 230–232.
  128. Shroff G, Gupta R. Human embryonic stem cells in the treatment of patients with spinal cord injury. Ann Neurosci. 2015 Oct;22(4):208-16. doi: 10.5214/ans.0972.7531.220404. PMID: 26526627; PMCID: PMC4627203.
  129. Shroff, G. (2015). Human embryonic stem cells in the treatment of patients with Duchenne muscular dystrophy: a case series. Journal of Neurology Research, 5(1–2), 186–191.
  130. Shroff, G., Use of human embryonic stem cells in the treatment of Age-Related Macular Degeneration. (2015). Journal of Clinical & Experimental Ophthalmology, 06(03).
  131. Geeta Shroff, Barthakur JK, Parul Mohan and Harsh Mahajan. (2015). Single Photon Emission Computed Tomography Scan as a Diagnostic Tool in Children with Cerebral Palsy Treated with Human Embryonic Stem Cells. Journal of Nuclear Medicine & Radiation Therapy, 06(03).
  132. Shroff, G. (2015). Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy. Molecular Therapy, 23, S262–S263.
  133. Shroff, G., Sonowal, N., (2015). Role of Anesthetists in Human Embryonic Stem Cells Transplantation in Patients with Spinal Cord Injury. Journal of Anesthesia & Clinical Research, 06(05).
  134. Shroff, G., & Das, L. (2015). Use of human embryonic stem cells (HESCs) in the treatment of glaucoma. International Journal of Medical and Pharmaceutical Case Reports, 4(3), 72–76.
  135. Shroff, G. (2015). Use of human embryonic stem cells in the treatment of diabetes mellitus: a case series. Journal of Diabetes Mellitus, 05(04), 313–318.
  136. Shroff, G. (2015). Human Embryonic Stem Cells in the Treatment of Patients with Traumatic Brain Injury. SOJ Neurology, 2(2), 01–04.
  137. Shroff G. Human Embryonic Stem Cell Therapy in Chronic Spinal Cord Injury: A Retrospective Study. Clin Transl Sci. 2016 Jun;9(3):168-75. doi: 10.1111/cts.12394. Epub 2016 May 3. PMID: 27144379; PMCID: PMC5351327.
  138. Shroff, G. (2016). Improved Epilepsy and Speech Outcomes with Human Embryonic Stem Cell Therapy in Children with Cerebral Palsy. International Archives of Medicine.
  139. Shroff, G. (2016). Therapeutic potential of human embryonic stem cells in type 2 diabetes mellitus. World Journal of Stem Cells, 8(7), 223.
  140. Shroff, G. (2016). Human embryonic stem cells in the treatment of patients with Down Syndrome: a case report. Journal of Medical Cases, 7(4), 123–125.
  141. Shroff, G. (2016). Use of Human Embryonic Stem Cells in the Treatment of Thrombocytopenia: A Case Series: hESC therapy in Thrombocytopenia. International Archives of Medicine.
  142. Shroff G, Thakur D, Dhingra V, Baroli DS, Khatri D, Gautam RD. Role of physiotherapy in the mobilization of patients with spinal cord injury undergoing human embryonic stem cells transplantation. Clin Transl Med. 2016 Dec;5(1):41. doi: 10.1186/s40169-016-0122-5. Epub 2016 Oct 20. PMID: 27766603; PMCID: PMC5073087.\
  143. Shroff G. Transplantation of Human Embryonic Stem Cells in Patients with Multiple Sclerosis and Lyme Disease. Am J Case Rep. 2016 Dec 13;17:944-949. doi: 10.12659/ajcr.899745. PMID: 27956736; PMCID: PMC5156555.
  144. Shroff G. Evaluation of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic stem cell therapy. Clin Transl Med. 2016 Dec;5(1):43. doi: 10.1186/s40169-016-0124-3. Epub 2016 Oct 20. PMID: 27766605; PMCID: PMC5073081.
  145. Shroff, G. (2016b). Human embryonic stem cell therapy in Crohn’s Disease: a case report. American Journal of Case Reports, 17, 124–128.
  146. Shroff G. Human Embryonic Stem Cells in the Treatment of Autism: A Case Series. Innov Clin Neurosci. 2017 Apr 1;14(3-4):12-16. PMID: 28584692; PMCID: PMC5451033.
  147. Shroff G, Gupta R, Zadeng L. Human embryonic stem cell therapy for aplastic anemia. Clin Case Rep. 2017 Apr 26;5(6):919-922. doi: 10.1002/ccr3.950. PMID: 28588839; PMCID: PMC5458044.
  148. Shroff G. Magnetic resonance imaging tractography as a diagnostic tool in patients with spinal cord injury treated with human embryonic stem cells. Neuroradiol J. 2017 Feb;30(1):71-79. doi: 10.1177/1971400916678221. Epub 2017 Jan 6. PMID: 28058985; PMCID: PMC5564331.
  149. Shroff G. Single-photon emission tomography imaging in patients with Lyme disease treated with human embryonic stem cells. Neuroradiol J. 2018 Apr;31(2):157-167. doi: 10.1177/1971400917742470. Epub 2018 Jan 4. PMID: 29300119; PMCID: PMC5882063.
  150. Bansal, H., Bansal, A., Bansal, A., Khan, I., Chrysostomou, K., Singh, S., & Leon, J. (2025). Clinical Evaluation of Ultrasonicated ADSCs in Atrophic Non-Union of Long Bones. medRxiv, 2025-07.
  151. Bansal, H., Singh, L., Verma, P., Agrawal, A., Leon, J., Sundell, I. B., & Koka, P. S. (2016). Administration of Autologous Bone Marrow-Derived Stem Cells for Treatment of Cerebral Palsy Patients: A Proof of Concept. Journal of Stem Cells, 11(1).
  152. Bansal, H., Verma, P., Agrawal, A., Leon, J., Sundell, I. B., & Koka, P. S. (2016). Autologous bone marrow-derived stem cells in spinal cord injury. Journal of stem cells, 11(1), 51.
  153. Bansal, H., Singh, L., Agrawal, A., Leon, J., Sundell, I. B., & Koka, P. S. (2016). Therapy with Bone Marrow-Derived Autologous Adult Stem Cells in Quadriparesis due to Motor Neuron Disease. Journal of Stem Cells, 11(1).
  154. Bansal, H., Singh, L., Verma, P., Agrawal, A., Leon, J., Sundell, I. B., & Koka, P. S. (2016). A Short Study Report on Bone Marrow Aspirate Concentrate Cell Therapy in Ten South Asian Indian Patients with Autism. Journal of Stem Cells, 11(1).
  155. Bansal, H., Bansal, A., Kachhap, M. N., Chowdhary, A., & Koka, P. S. (2015). Therapeutic Application of Bone Marrow-Derived Stem Cells in a Patient with Methanol-Induced Blindness. Journal of stem cells, 10(1).
  156. Bansal, K., Jha, C. K., Bhatia, D., & Shekhar, H. (2021). Ultrasound-enabled therapeutic delivery and regenerative medicine: physical and biological perspectives. ACS Biomaterials Science & Engineering, 7(9), 4371-4387.
  157. Verma, P., Bansal, H., Agrawal, A., Leon, J., Sundell, I. B., & Koka, P. S. (2016). Evaluation of bone marrow processing protocol for therapeutic applications via culture and characterization of mesenchymal stem cells. Journal of Stem Cells, 11(1), 3.
  158. Bansal, H., Bansal, A., Agrawal, D., Singh, D., & Deb, K. (2014). Chondroprotection using naturally occurring mineral supplementation formula in degenerative osteoarthritis of the knees. Journal of Stem Cells, 9(1), 65.
  159. Bansal, H., Leon, J., Pont, J. L., Wilson, D. A., ST, S. M., Bansal, A., & Preoteasa, I. (2020). Clinical Efficacy of a Single-Dose of Platelet Rich Plasma in the Management of Early Knee Osteoarthritis: A Randomized Controlled Study with Mri Assessment and Evaluation of Optimal Dose.
  160. Rajput BS, Chakrabarti SK, Dongare VS, Ramirez CM, Deb KD. Human umbilical cord mesenchymal stem cells in the treatment of Duchenne muscular dystrophy: safety and feasibility study in India. Journal of stem cells. 2015 Apr 1;10(2):141.
  161. Ravikumar R, Narayanan S, Baskar S, Nagarajan RS, Abraham S. Autologous stem cell injection for spinal cord injury-a clinical study from India. Journal of stem cells & regenerative medicine. 2007;3(1):24.
  162. Kumar AA, Kumar SR, Narayanan R, Arul K, Baskaran M. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I/II clinical safety and primary efficacy data. Exp Clin Transplant. 2009 Dec 1;7(4):241-8.
  163. Subbaiah GP, Adavi V, Chelluri LK, Laxman S, Ratnakar K, Gopal P, Ravindranath K. Preliminary report on the safety, efficay and functional recovery of spinal cord injury with autologous bone marrow derived mesenchymal stem cells-a clinical trial. Internet J Spine Surg. 2009;5.
  164. Chhabra HS, Lima C, Sachdeva S, mittal A, Nigam V, Chaturvedi D, Arora M, Aggarwal A, Kapur R, Khan TA. Autologous olfactory mucosal transplant in chronic spinal cord injury: an Indian Pilot Study. Spinal Cord. 2009 Dec;47(12):904.
  165. Tripathy P, Dash C, Rath A, Chakraborty S, Sahoo J, Mohanty S. Autologous bone marrow derived stem cell therapy in traumatic spinal cord injury: A case report and review of literature. The Indian Journal of Neurotrauma [Internet]. 2014 Dec [cited 2022 Sep 22];11(2):150-3.
  166. Prasad K, Sharma A, Garg A, Mohanty S, Bhatnagar S, Johri S, Singh KK, Nair V, Sarkar RS, Gorthi SP, Hassan KM. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke. 2014 Dec;45(12):3618-24.
  167. Prasad K, Mohanty S, Bhatia R, Srivastava MV, Garg A, Srivastava A, Goyal V, Tripathi M, Kumar A, Bal C, Vij A. Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study. The Indian journal of medical research. 2012 Aug;136(2):221.
  168. Prabhakar S, Marwaha N, Lal V, Sharma RR, Rajan R, Khandelwal N. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study. Neurol India. 2012 Oct;60(5):465–9.
  169. Muthu, S., Jeyaraman, M., Gulati, A., & Arora, A. (2020). Current evidence on mesenchymal stem cell therapy for traumatic spinal cord injury: systematic review and meta-analysis. Cytotherapy, 23(3), 186–197.
  170. Najar, A. H., Sneha, K. M., Ashok, A., Babu, S., Subramaniam, A. G., Kannan, R., … Jain, S. (2019). Derivation of iPSC lines from two patients with familial Alzheimer’s disease from India. Stem Cell Research, 34, 101370. doi:10.1016/j.scr.2018.101370
  171. Bhatt, A., Bhardwaj, H., & Srivastava, P. (2024). Mesenchymal stem cell therapy for Alzheimer’s disease: A novel therapeutic approach for neurodegenerative diseases. Neuroscience, 555, 52–68.
  172. K S, HC S. Effectiveness of Stem Cell Therapy in Autism Spectrum Disorders: Case Study of Identical Twins. Austin Journal of Autism & Related Disabilities [Internet]. 2021 Sep 23 [cited 2022 Aug 30];7(1).
  173. Singh A, Gangwar DS, Singh S. Bone marrow injection: A novel treatment for tennis elbow. J Nat Sci Biol Med. 2014 Jul-Dec;5(2):389-91. doi: 10.4103/0976-9668.136198.
  174. Varma HS, Dadarya B, Vidyarthi A. The new avenues in the management of osteo-arthritis of knee--stem cells. J Indian Med Assoc. 2010 Sep;108(9):583-5.
  175. Vaish, A., & Vaishya, R. (2024). Stem cells in orthopaedics and sports injuries: A comprehensive review and future research directions. Journal of Orthopaedic Reports, 3(4), 100344.
  176. Gupta PK, Chullikana A, Parakh R, Desai S, Das A, Gottipamula S, Krishnamurthy S, Anthony N, Pherwani A, Majumdar AS. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia. J Transl Med. 2013 Jun 10;11:143.
  177. Jain P, Perakath B, Jesudason MR, Nayak S. The effect of autologous bone marrow-derived cells on healing chronic lower extremity wounds: results of a randomized controlled study. Ostomy Wound Manage. 2011 Jul;57(7):38-44.
  178. Sharma S et al. Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous Bone Marrow- Derived Stem Cells in Patients with Severe Peripheral Arterial Disease. J Vasc Interv Radiol. 2021 Feb;32(2):157-163.
  179. Chittoria RK, Nandhagopal V, Mohapatra DP, Thiruvoth FM, Sivakumar DK, Asokan A. Autologous Bone Marrow Aspirate Therapy in Wound Healing. Adv Wound Care (New Rochelle). 2016 Mar 1;5(3):102-105.
  180. Gupta P K et al. Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled,Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease:Phase II Study Report Suggests Clinical Efficacy. Stem Cells Transl Med. 2017 Mar;6(3):689-699
  181. Subrammaniyan R, Amalorpavanathan J, Shankar R, Rajkumar M, Baskar S, Manjunath S, Senthilkumar R, Abraham S. Our experience of application of Autologous Bone Marrow Stem Cells in critical limb ischemia in six diabetic patients - A five-year follow-up. J Stem Cells Regen Med. 2011 Oct 30;7(2):97. eCollection
  182. Shukla VK, Tiwary SK, Barnwal S, Gulati AK, Pandey SS. Effect of autologous epidermal cell suspension transplantation in chronic nonhealing wounds: a pilot study. Can J Surg. 2010 Feb;53(1):6-10.
  183. Gupta PC, Chukka K, Yerramsetty V, Atturu G. Long-term Results of Stem Cell Therapy for Acute and Chronic Limb Ischemia. Journal of Vascular Surgery. 2021;74(3):e50-e51.
  184. Bhansali, A., Asokumar, P., Walia, R., Bhansali, S., Gupta, V., Jain, A., Sachdeva, N., Sharma, R. R., Marwaha, N., & Khandelwal, N. (2013). Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study. Cell Transplantation, 23(9), 1075–1085.
  185. Bhansali, S., Dutta, P., Kumar, V., Yadav, M. K., Jain, A., Mudaliar, S., Bhansali, S., Sharma, R. R., Jha, V., Marwaha, N., Khandelwal, N., Srinivasan, A., Sachdeva, N., Hawkins, M., & Bhansali, A. (2016). Efficacy of autologous Bone Marrow-Derived Mesenchymal stem cell and mononuclear cell transplantation in Type 2 diabetes mellitus: a randomized, Placebo-Controlled comparative study. Stem Cells and Development, 26(7), 471–481.
  186. Thakkar, U. G., Trivedi, H. L., Vanikar, A. V., & Dave, S. D. (2015). Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow–derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. Cytotherapy, 17(7), 940–947.
  187. Vanikar, A. V., Dave, S. D., Thakkar, U. G., & Trivedi, H. L. (2010). Cotransplantation of adipose Tissue-Derived Insulin-Secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for Insulin-Dependent diabetes mellitus. Stem Cells International, 2010, 1–5.
  188. Bhansali, A., Upreti, V., Khandelwal, N., Marwaha, N., Gupta, V., Sachdeva, N., Sharma, R., Saluja, K., Dutta, P., Walia, R., Minz, R., Bhadada, S., Das, S., & Ramakrishnan, S. (2009). Efficacy of autologous Bone Marrow–Derived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells and Development, 18(10), 1407–1416.
  189. Trivedi, H., Vanikar, A., Thakker, U., Firoze, A., Dave, S., Patel, C., Patel, J., Bhargava, A., & Shankar, V. (2008). Human adipose Tissue-Derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transplantation Proceedings, 40(4), 1135–1139.
  190. Dave SD, Trivedi HL, Chooramani SG, Chandra T. Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells. Case Reports. 2013 Jul 26 ;2013(jul26 1):bcr2013200226.
  191. Singh, A., Afshan, N., Singh, A., Singh, S. K., Yadav, S., Kumar, M., ... & Verma, V. (2023). Recent trends and advances in type 1 diabetes therapeutics: A comprehensive review. European journal of cell biology, 102(2), 151329.
  192. Ajgaonkar, B. S., Kumaran, A., Kumar, S., Jain, R. D., & Dandekar, P. P. (2023). Cell-based therapies for corneal and retinal disorders. Stem Cell Reviews and Reports, 19(8), 2650-2682.
  193. Khan AA, Parveen N, Mahaboob VS, Rajendraprasad A, Ravindraprakash HR, Venkateswarlu J, Rao SG, Narusu ML, Khaja MN, Pramila R, Habeeb A. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. InTransplantation proceedings 2008 May 1 (Vol. 40, No. 4, pp. 1140-1144). Elsevier.
  194. Mahendiratta, S., Bansal, S., Sarma, P., Kumar, H., Choudhary, G., Kumar, S., Prakash, A., Sehgal, R., & Medhi, B. (2021). Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review. Biomedicine & Pharmacotherapy, 137, 111300.